Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-050033

Chief Business Officer sold 18,000 shares at $8.66 ($155,880)

  • Chief Business Officer acquired 18,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Virani Shafique · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-15 Exercise or conversion : show line 1 in the form 10b5-1 +18,000 $2.22 $39,960 158,351 D
2023-09-15 Sale : show line 2 in the form 10b5-1 −18,000 $8.66 $155,880 140,351 D
Open-market sales · 18,000 sh · avg $8.66 · $155,880

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-15 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −18,000 $2.22 2030-03-03 18,000 433,469 D
Loading xslF345X05/doc4.xml…